Avid Bioservices Inc (CDMO)

[jakedogman1]

AZN needs big time help....

http://www.fiercebiotech.com/story/astrazeneca-hit-another-setback-durvalumab-disappoints-lung-cancer/2015-12-18

Now if pphm mgmt cannot figure out how to make a deal under the current situation, they are in way over their heads. I'm talking about representing shareholders in taking the risk out of the equation.... imo right now the share price should be much greater than the paid in capital.. it is way below.... there is leverage with the pipeline issue and there is leverage with the needs of some bp's as well ....

also it's not always the best drug that wins.... time to approval is just as important.... and speed requires resources and lots of cash...

it's not rocket science...